Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc. (NYSE: CLS; TSX: CLS) is back in the spotlight on December 15, 2025 after a sharp pullback that reminded investors of an uncomfortable truth: even “AI infrastructure winners” can get whipsawed when the market mood flips. On the NYSE, Celestica closed at $306.50 on December 12, down $44.91 (-12.78%), and was indicated higher in early pre-market trading on December 15 around $312.10 (+1.83%). StockAnalysis So what’s driving the move, what’s new in today’s news flow, and what do forecasts look like heading into 2026? Why Celestica stock dropped: the selloff was bigger than one company The most important
15 December 2025
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping Services Ltd. stock is back in the spotlight on Dec. 15, 2025, caught at the intersection of three forces that can yank any shipping name around: freight-rate expectations, corporate control drama, and the always-contentious question of how much cash a cyclical carrier should return to shareholders. As of the latest available trading update, ZIM shares were around $18.76, down about 5.4% from the prior close—an intraday move that underscores how headline-sensitive the stock has become as takeover speculation heats up and a high-stakes shareholder vote approaches. ZIM Investors Why ZIM stock is moving now: M&A rumors collide
Geminids Meteor Shower 2025: The Asteroid Behind Today’s Shooting Stars (Dec. 15 Updates)

Geminids Meteor Shower 2025: The Asteroid Behind Today’s Shooting Stars (Dec. 15 Updates)

On December 15, 2025, the Geminids — often called the year’s most reliable “shooting star” show — are still making headlines around the world. While peak activity has largely passed, late-season Geminid meteors are continuing to streak across dark skies, and today’s coverage has put renewed focus on the shower’s strangest detail: the Geminids come from an asteroid, not a comet. NASA Science+1 If you’re searching for “Geminids asteroid today,” you’re almost certainly looking for the story of asteroid 3200 Phaethon — a rocky object that behaves like a comet at times, leaving behind the debris Earth plows into each December. NASA Science+1 Geminids meteor shower
15 December 2025
Canada Economic Calendar Today (Dec. 15, 2025): CPI, Housing Starts and Factory Data in Focus as Bank of Canada Watchers Brace for Volatility

Canada Economic Calendar Today (Dec. 15, 2025): CPI, Housing Starts and Factory Data in Focus as Bank of Canada Watchers Brace for Volatility

Canada’s economic calendar today is packed into a narrow early-morning window, with inflation, housing and manufacturing releases expected to steer the Canadian dollar, bond yields and interest-rate expectations into the week. The headline event is Statistics Canada’s November Consumer Price Index (CPI), published this morning as part of a new Monday release cadence. Statistics Canada+1 But before CPI hits, traders and economists are also parsing national MLS home sales data and scanning housing starts and manufacturing shipments for signals about growth momentum heading into year-end. Scotiabank+2GlobeNewswire+2 Below is what’s on the Canada economic calendar today, what the latest news is saying, and how forecasters think the data could shape the
15 December 2025
US Economic Calendar Today (Dec. 15, 2025): Empire State Manufacturing, NAHB Housing Index, Fed Speaker Williams, and Treasury Bill Auctions

US Economic Calendar Today (Dec. 15, 2025): Empire State Manufacturing, NAHB Housing Index, Fed Speaker Williams, and Treasury Bill Auctions

Wall Street starts the week with a compact but market-sensitive U.S. economic calendar today, Monday, December 15, 2025—headlined by the New York Fed’s Empire State Manufacturing Survey, the NAHB/Wells Fargo Housing Market Index, and remarks from New York Fed President John C. Williams. Treasury bill auctions also add an important rates-and-liquidity check-in for investors watching the front end of the curve. The backdrop matters more than usual: a recent, record-length U.S. government shutdown disrupted data collection, pushed back key releases, and left holes in the official economic record—meaning this week’s delayed jobs and inflation prints may come with extra caveats
15 December 2025
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) entered a new phase in its corporate life this month: from clinical-stage story stock to a company with an FDA-approved, commercially launchable cardiovascular product. The catalyst is CARDAMYST™ (etripamil) nasal spray, now approved in the U.S. for adults experiencing acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT)—a rapid heart rhythm disturbance that can be frightening, disruptive, and costly when it sends patients to emergency care. GlobeNewswire Yet in classic biotech fashion, the stock market’s reaction has been anything but simple. Despite the “yes” from regulators, MIST shares saw sharp volatility into the weekend, and investors
GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace stock is back in the market’s spotlight heading into mid-December, trading around $299.81 and up roughly 4% versus the prior close in the latest available quote. That move isn’t happening in a vacuum. Over the past several days, GE has landed fresh bullish Wall Street coverage, surfaced in defense-related headlines, and found itself indirectly tied to a regulatory development affecting the CFM LEAP engine family—one of the most important programs in modern commercial aviation. Below is what’s driving GE Aerospace stock right now, how analysts are framing upside (and limits), and what investors will be watching as GE
Night Sky Tonight (Dec. 15, 2025): Geminids Encore, Orion Nebula Peak, and a Rare Interstellar Comet Turns Green

Night Sky Tonight (Dec. 15, 2025): Geminids Encore, Orion Nebula Peak, and a Rare Interstellar Comet Turns Green

December 15, 2025 brings a near-perfect recipe for skywatchers: long winter nights, a slim waning Moon, and a sky full of headline-worthy targets—plus a rare interstellar visitor that’s suddenly glowing green in new images. With the winter solstice now just days away, the Northern Hemisphere is sliding toward the longest night of the year, while the Southern Hemisphere moves toward summer’s shorter nights. Either way, tonight’s sky has something for everyone, from casual stargazers stepping outside for five minutes to telescope owners planning a pre-dawn session. The Guardian Below is a news-style roundup of what’s trending today (15.12.2025)—followed by a practical “what to see tonight” guide you can use anywhere
15 December 2025
Comet 3I/ATLAS Today (Dec. 15, 2025): The Interstellar Visitor Turns Green Ahead of Its Dec. 19 Flyby

Comet 3I/ATLAS Today (Dec. 15, 2025): The Interstellar Visitor Turns Green Ahead of Its Dec. 19 Flyby

On December 15, 2025, the solar system’s most talked-about “visitor” is back in headlines for two very comet-like reasons: it’s brightening and it’s glowing green. The object is Comet 3I/ATLAS—often shortened to “3I/Atlas comet”—the third confirmed interstellar object ever found passing through our neighborhood, after 1I/ʻOumuamua (2017) and 2I/Borisov (2019). Space+1 Today’s coverage is focusing on what observers are seeing now that 3I/ATLAS has re-emerged for sustained viewing after its late-October solar passage: a more active coma, a greener tint, and renewed discussion of a quirky-looking feature known as an anti-tail. The Times of India+2Digit+2 With the comet set to make its closest approach to Earth on December 19—still a very safe ~270 million kilometers
15 December 2025
Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron Technology, Inc. (NASDAQ: MU) heads into mid-December with one big, market-moving catalyst: its fiscal first-quarter 2026 earnings report and conference call on Wednesday, Dec. 17, 2025. Micron Technology+1 After an explosive 2025 run—Micron shares have gained more than 200% year-to-date in some tallies—investors are now trying to answer a more delicate question: Is MU still in the early innings of an “AI memory supercycle,” or are expectations so high that even good results could trigger a sell-the-news reaction? Investopedia As of the latest available quote in this briefing, MU is around $241.14, which implies a roughly 6.7% drop versus
Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare Inc. (NASDAQ: IXHL) is back on traders’ radar heading into mid-December, with the stock hovering around $0.42 in early Monday pricing on December 15, 2025, after closing near $0.40 in the prior session. The renewed attention isn’t coming out of nowhere. Over the past several weeks, Incannex has stacked up a series of developments that matter to speculative biotech investors: a U.S. FDA Fast Track designation for its lead obstructive sleep apnea (OSA) program, a Nasdaq minimum bid-price compliance deadline now pushed into 2026, and fresh research commentary from at least one boutique coverage firm—along with a mixed
15 December 2025
ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

December 15, 2025 — ImmunityBio, Inc. (NASDAQ: IBRX) is back on investors’ radar today as fresh coverage and new analysis dig into a major European regulatory milestone for its lead therapy ANKTIVA (nogapendekin alfa inbakicept). The market’s obsession is simple: does this become the catalyst that turns ImmunityBio into a real commercial oncology story—or just the latest biotech pop before the harder work of reimbursement, uptake, and cash management begins? Below is a complete, publication-ready roundup of the news, forecasts, and market analysis circulating on December 15, 2025, plus the key fundamentals investors are weighing right now. Why ImmunityBio stock

Stock Market Today

Alphabet stock drops for a fourth straight day as AI spending jitters linger

Alphabet stock drops for a fourth straight day as AI spending jitters linger

7 February 2026
Alphabet shares fell 2.53% to $322.86 Friday, marking a fourth straight decline as investors questioned heavy AI-related spending. The Nasdaq slipped Thursday after Alphabet detailed up to $185 billion in capex, while the Dow and S&P 500 rose Friday on chipmaker gains. U.S. markets reopen Monday, with attention on Alphabet’s outlook and upcoming jobs and inflation data.
BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

7 February 2026
BigBear.ai Holdings shares surged 15.7% Friday to $4.72 ahead of a key shareholder vote on doubling authorized shares to 1 billion. Options trading was heavy, with a put/call ratio of 0.19. The company recently announced deals in AI customs technology and a partnership with Abu Dhabi’s AD Ports Group. The special meeting is set for Feb. 18, with online voting open until late Feb. 17.
American Airlines stock jumps nearly 8% as airlines rally — what to watch next week

American Airlines stock jumps nearly 8% as airlines rally — what to watch next week

7 February 2026
American Airlines shares jumped 7.6% to $15.24 Friday, rebounding with a broad rally that sent the Dow past 50,000 for the first time. Investors are watching the carrier’s battle with United at Chicago O’Hare, where a summer capacity surge could trigger a fare war. American also announced new Philadelphia–Porto service for 2027 and launched a centennial inflight menu.
Go toTop